Viracta Therapeutics (NASDAQ:VIRX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Viracta Therapeutics (VIRX) operate in?

Viracta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Viracta Therapeutics Stock (NASDAQ: VIRX) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 89.76K
Day Range	- - -
52 Wk Range	0.43 - 1.68
Market Cap	$22.67M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	2.34%
Days to Cover	8.36

Recent News

Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.

Avi Kapoor

Why Is Small-Cap Cancer Drug Developer Viracta Therapeutics Stock Trading Lower On Monday?

Nanatinostat combined with valganciclovir shows promising results in treating relapsed or refractory EBV+ peripheral T-cell lymphoma, demonstrating higher efficacy and tolerability than nanatinostat monotherapy.

Vandana Singh

Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Viracta Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicine...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Viracta Therapeutics (VIRX) stock?

You can purchase shares of Viracta Therapeutics (NASDAQ:VIRX) through any online brokerage.

View our list of the best stock brokerages

Who are Viracta Therapeutics (VIRX) competitors?

Other companies in Viracta Therapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Nanoviricides (AMEX:NNVC), Can Fite Biofarma (AMEX:CANF), Sensei Biotherapeutics (NASDAQ:SNSE) and GlycoMimetics (NASDAQ:GLYC).

What is the target price for Viracta Therapeutics (VIRX) stock?

There is no analysis for Viracta Therapeutics.

What is the forecast for Viracta Therapeutics (VIRX) stock?

Viracta Therapeutics has a consensus price target of $7.20.

Current stock price for Viracta Therapeutics (VIRX)?

The stock price for Viracta Therapeutics (NASDAQ: VIRX) is $0.5773 last updated July 17, 2024 at 7:56 AM EDT.

Does Viracta Therapeutics (VIRX) pay a dividend?

There are no upcoming dividends for Viracta Therapeutics.

When is Viracta Therapeutics (NASDAQ:VIRX) reporting earnings?

Viracta Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.

Is Viracta Therapeutics (VIRX) going to split?

There is no upcoming split for Viracta Therapeutics.

What sector and industry does Viracta Therapeutics (VIRX) operate in?

Viracta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Viracta Therapeutics

Viracta Therapeutics (VIRX) Forecast